The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $177.31

Today's change-2.15 -1.20%
Updated September 2 10:53 AM EDT. Delayed by at least 15 minutes.
 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $177.31

Today's change-2.15 -1.20%
Updated September 2 10:53 AM EDT. Delayed by at least 15 minutes.

Perrigo Company PLC down (U.S.)$2.15

Perrigo Company PLC is lower today, dropping (U.S.)$2.15 or 1.20% to (U.S.)$177.31. Shares have lost 3.51% over the last five days, but have gained 6.07% over the last year to date. This security has outperformed the S&P 500 by 23.05% during the last year.

Key company metrics

  • Open(U.S.) $180.79
  • Previous close(U.S.) $179.46
  • High(U.S.) $181.46
  • Low(U.S.) $177.15
  • Bid / Ask(U.S.) $177.43 / (U.S.) $177.66
  • YTD % change+6.07%
  • Volume169,702
  • Average volume (10-day)1,384,696
  • Average volume (1-month)1,387,686
  • Average volume (3-month)1,274,019
  • 52-week range(U.S.) $135.00 to (U.S.) $215.73
  • Beta0.31
  • Trailing P/E195.50×
  • P/E 1 year forward20.20×
  • Forward PEG1.69×
  • Indicated annual dividend(U.S.) $0.50
  • Dividend yield0.28%
  • Trailing EPS(U.S.) $0.91
Updated September 2 10:53 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+2.78%

Based on its net profit margin of 2.78%, Perrigo Company PLC is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.23%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 27, 201506/27/2015Mar 28, 201503/28/2015Dec 27, 201412/27/2014Sep 27, 201409/27/2014
Revenue1,5321,0491,072952
Total other revenue--------
Total revenue1,5321,0491,072952
Gross profit628379384322
Total cost of revenue903670688630
Total operating expense1,306850897814
Selling / general / administrative339143144146
Research & development63355337
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)11122
Other operating expenses, total--------
Operating income226199175137
Interest income (expense), net non-operating-47-43-31-26
Gain (loss) on sale of assets--------
Other--------
Income before tax157-10385109
Income after tax57-957096
Income tax, total101-81512
Net income57-957096
Total adjustments to net income--------
Net income before extra. items57-957096
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items57-957096
Inc. avail. to common incl. extra. items57-957096
Diluted net income57-957096
Dilution adjustment--------
Diluted weighted average shares147141137134
Diluted EPS excluding extraordinary itemsvalue per share0.39-0.670.510.72
Dividends per sharevalue per share0.130.130.110.11
Diluted normalized EPSvalue per share0.39-0.670.590.73